A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies

NCT00162123 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
248
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb